|
US20080220025A1
(en)
*
|
1995-03-17 |
2008-09-11 |
James Thompson |
Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
|
|
US7361332B2
(en)
*
|
1995-03-17 |
2008-04-22 |
The Regents Of The University Of California |
Treating tumors using implants comprising combinations of allogeneic cells
|
|
AU7154598A
(en)
*
|
1997-04-23 |
1998-11-13 |
Regents Of The University Of California, The |
A cell strain with activated anti-cancer cytotoxic activity
|
|
EP1021197B1
(en)
*
|
1997-10-10 |
2007-04-11 |
The Regents of the University of California |
Implants comprising combinations of allogeneic cells for use in cancer treatment
|
|
WO1999019462A1
(en)
*
|
1997-10-10 |
1999-04-22 |
The Regents Of The University Of California |
Enhanced immunogenic cell populations prepared using h2 receptor antagonists
|
|
WO1999018980A1
(en)
|
1997-10-10 |
1999-04-22 |
Meyer Pharmaceuticals, Llc |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
|
|
JP4389039B2
(ja)
*
|
1998-04-09 |
2009-12-24 |
株式会社リンフォテック |
アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット
|
|
US7666609B1
(en)
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
|
HK1041831B
(en)
*
|
1999-02-09 |
2009-05-22 |
理化学研究所 |
Tumor vaccines
|
|
US7303911B2
(en)
|
2000-04-01 |
2007-12-04 |
Onyvax Limited |
Prostate cell lines
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
DE10043437A1
(de)
*
|
2000-09-04 |
2002-03-28 |
Horst Lindhofer |
Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites
|
|
US20040191246A1
(en)
|
2003-02-26 |
2004-09-30 |
Connelly Patrick R. |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
CN1332712C
(zh)
*
|
2001-05-11 |
2007-08-22 |
沃尔斯泰特生物制剂公司 |
肿瘤消解病毒疗法
|
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
EP1451332B1
(en)
*
|
2001-11-27 |
2008-02-13 |
neXyte AB |
Production of eukaryotic proteins and nucleic acid molecules in c. elegans
|
|
KR20020060643A
(ko)
*
|
2002-06-04 |
2002-07-18 |
김진경 |
타인의 면역시스템을 이용하는 암의 치료 방법
|
|
AU2003258090B2
(en)
*
|
2002-08-08 |
2010-07-22 |
Baylor College Of Medicine |
Isolation and identification of T cells
|
|
US7571817B2
(en)
*
|
2002-11-06 |
2009-08-11 |
Varco I/P, Inc. |
Automatic separator or shaker with electromagnetic vibrator apparatus
|
|
KR20040094635A
(ko)
*
|
2003-05-02 |
2004-11-10 |
주식회사 엠디바이오알파 |
항종양 활성의 유도를 위한 종양 백신의 제조방법 및그것을 함유하고 있는 약제 조성물
|
|
CA2529058A1
(en)
|
2003-06-11 |
2005-01-13 |
The University Of Chicago |
Increased t-cell tumor infiltration by mutant light
|
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
|
US20050019336A1
(en)
|
2003-07-23 |
2005-01-27 |
Dalgleish Angus George |
Human prostate cell lines in cancer treatment
|
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
|
JP2007508018A
(ja)
*
|
2003-10-08 |
2007-04-05 |
べト−ステム インコーポレイテッド |
新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
|
|
US8029454B2
(en)
*
|
2003-11-05 |
2011-10-04 |
Baxter International Inc. |
High convection home hemodialysis/hemofiltration and sorbent system
|
|
US20050112684A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Eric Holzle |
Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners
|
|
CN1950518A
(zh)
|
2004-02-03 |
2007-04-18 |
密执安州立大学董事会 |
表征、调节、诊断和治疗癌症的组合物和方法
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
US8257715B1
(en)
|
2004-08-26 |
2012-09-04 |
University Of Notre Dame |
Tissue vaccines and uses thereof
|
|
US9155789B2
(en)
*
|
2005-04-25 |
2015-10-13 |
New York University |
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
|
|
US20090162405A1
(en)
*
|
2006-12-14 |
2009-06-25 |
Yong Qian |
Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
|
|
US8802113B2
(en)
*
|
2005-10-27 |
2014-08-12 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US9308252B2
(en)
*
|
2005-10-27 |
2016-04-12 |
Cook Biotech, Inc. |
Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
|
|
US8778360B2
(en)
*
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US8778362B2
(en)
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
|
|
PL2481756T3
(pl)
|
2005-10-31 |
2018-02-28 |
Oncomed Pharmaceuticals, Inc. |
Kompozycje i sposoby diagnozowania i leczenia nowotworu
|
|
US7723477B2
(en)
*
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
WO2007053648A2
(en)
*
|
2005-10-31 |
2007-05-10 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070243192A1
(en)
*
|
2006-02-21 |
2007-10-18 |
Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
WO2007131210A2
(en)
*
|
2006-05-05 |
2007-11-15 |
Opexa Therapeutics |
T-cell vaccine
|
|
PT2511301T
(pt)
|
2006-08-04 |
2018-03-08 |
Medimmune Ltd |
Anticorpos humanos para erbb2
|
|
US7972594B2
(en)
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
|
US8691568B2
(en)
*
|
2006-11-22 |
2014-04-08 |
Hua Liu |
Method for preparing cell populations with anti-tumor immune response activity
|
|
US20080147007A1
(en)
*
|
2006-12-19 |
2008-06-19 |
Toby Freyman |
Delivery device with pressure control
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CN101641010A
(zh)
*
|
2007-01-26 |
2010-02-03 |
路易斯维尔大学研究基金会公司 |
用作疫苗的外来体组分的修饰
|
|
WO2008098183A2
(en)
*
|
2007-02-08 |
2008-08-14 |
The University Of Chicago |
Combination therapy for treating cancer
|
|
WO2008144029A1
(en)
|
2007-05-14 |
2008-11-27 |
The University Of Chicago |
Antibody-light fusion products for cancer therapeutics
|
|
EP2195650B1
(en)
*
|
2007-09-12 |
2016-07-06 |
Yeda Research And Development Company Ltd. |
Methods of treating tumors in immune-privileged sites
|
|
US8114276B2
(en)
|
2007-10-24 |
2012-02-14 |
Baxter International Inc. |
Personal hemodialysis system
|
|
US9283266B2
(en)
*
|
2008-02-28 |
2016-03-15 |
University Of Notre Dame |
Metastasis inhibition preparations and methods
|
|
NZ592338A
(en)
|
2008-09-26 |
2012-11-30 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
AU2009308707A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
EP2356462B1
(en)
|
2008-11-11 |
2017-01-04 |
The Regents of the University of Michigan |
Anti-cxcr1 compositions and methods
|
|
CU23740A1
(es)
*
|
2009-09-29 |
2011-12-28 |
Ct Ingenieria Genetica Biotech |
Método de obtención de una formulación de antígenos del virus de la hepatitis b
|
|
BR112012009962A2
(pt)
*
|
2009-10-27 |
2015-09-15 |
Immunicum Ab |
método para a proliferação de células tantígeno específicas.
|
|
AU2010341703B2
(en)
*
|
2009-12-08 |
2016-01-21 |
The Board Of Trustees Of The University Of Illinois |
Stem cell immune modulation methods of use and apparatus
|
|
US8846059B2
(en)
|
2009-12-08 |
2014-09-30 |
University Of Notre Dame |
Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
|
|
US20110150934A1
(en)
*
|
2009-12-18 |
2011-06-23 |
University Of Notre Dame |
Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
EP3450979A3
(en)
|
2010-03-17 |
2019-04-24 |
The Regents of The University of Michigan |
Using phage epitopes to profile the immune response
|
|
AU2011235904B2
(en)
|
2010-04-01 |
2015-10-08 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
WO2011129348A1
(ja)
*
|
2010-04-13 |
2011-10-20 |
株式会社Ｒｅｉメディカル |
癌組織由来細胞塊または癌細胞凝集塊から得られる癌治療用組成物およびそれを用いた免疫療法剤の製造方法ならびに免疫療法効果評価方法
|
|
PL2704741T3
(pl)
|
2011-05-03 |
2018-02-28 |
Immunovative Therapies, Ltd. |
Sposoby postępowania z lekami biologicznymi zawierającymi żywe komórki
|
|
HRP20230443T1
(hr)
*
|
2011-05-24 |
2023-09-15 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
|
CA2858876A1
(en)
|
2011-12-15 |
2013-06-20 |
The University Of Chicago |
Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
|
|
US9266959B2
(en)
|
2012-10-23 |
2016-02-23 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using frizzled-binding agents
|
|
US9359444B2
(en)
|
2013-02-04 |
2016-06-07 |
Oncomed Pharmaceuticals Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
CA2925104A1
(en)
*
|
2013-09-27 |
2015-04-02 |
Vaccinogen International Partners, Lp |
Autologous tumor vaccines and methods
|
|
CN119345231A
(zh)
|
2014-11-05 |
2025-01-24 |
纪念斯隆-凯特林癌症中心 |
选择用于过继细胞疗法的t细胞系及其供体的方法
|
|
WO2016145292A1
(en)
*
|
2015-03-12 |
2016-09-15 |
University Of Iowa Research Foundation |
Vaccine, therapeutic composition and methods for treating or inhibiting cancer
|
|
CN107921065A
(zh)
*
|
2015-06-26 |
2018-04-17 |
纪念斯隆-凯特林癌症中心 |
通过t细胞疗法治疗cmv视网膜炎的方法
|
|
WO2017023803A1
(en)
|
2015-07-31 |
2017-02-09 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
CN109068658A
(zh)
|
2015-11-18 |
2018-12-21 |
杜克大学 |
用于治疗癌症的肿瘤浸润淋巴细胞
|
|
CA3041068A1
(en)
|
2016-10-18 |
2018-04-26 |
Regents Of The University Of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
WO2018138682A1
(en)
|
2017-01-26 |
2018-08-02 |
Immune Therapeutics |
Methods and compositions useful for treating cancer
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
JP2020530307A
(ja)
|
2017-06-30 |
2020-10-22 |
インティマ・バイオサイエンス，インコーポレーテッド |
遺伝子治療のためのアデノ随伴ウイルスベクター
|
|
KR102256337B1
(ko)
*
|
2017-10-17 |
2021-05-26 |
(주)노터스생명과학 |
조직이식을 위한 세포배양액을 포함하는 면역억제제
|
|
US11446329B2
(en)
|
2017-11-01 |
2022-09-20 |
Restem Llc |
Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
FR3082730B1
(fr)
|
2018-06-21 |
2022-04-22 |
Med Inn Pharma |
Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique
|
|
WO2023196232A1
(en)
*
|
2022-04-04 |
2023-10-12 |
University Of Florida Research Foundation, Inc. |
Method of characterizing tumors
|
|
CN114984199A
(zh)
*
|
2022-04-19 |
2022-09-02 |
苏州尔生生物医药有限公司 |
一种基于癌症特异性t细胞的细胞系统、淋巴细胞药物及其应用
|